The estimated Net Worth of Katherine C. Doyle is at least $771 Mille dollars as of 14 May 2024. Ms. Doyle owns over 8,764 units of Perrigo plc stock worth over $512,414 and over the last 12 years she sold PRGO stock worth over $258,987. In addition, she makes $0 as Director at Perrigo plc.
Sign up
Ms. Doyle PRGO stock SEC Form 4 insiders trading
Katherine has made over 6 trades of the Perrigo plc stock since 2013, according to the Form 4 filled with the SEC. Most recently she exercised 8,764 units of PRGO stock worth $264,848 on 14 May 2024.
The largest trade she's ever made was exercising 8,764 units of Perrigo plc stock on 14 May 2024 worth over $264,848. On average, Katherine trades about 2,372 units every 257 days since 2013. As of 14 May 2024 she still owns at least 19,170 units of Perrigo plc stock.
You can see the complete history of Ms. Doyle stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Katherine Doyle biography
Katherine C. Doyle has been appointed as Director of the Company effective 7/29/2020. From 2016 to 2019, Ms. Doyle served as the Chief Executive Officer of Swanson Health Products, Inc., an e-commerce health and wellness self-care company. Prior to that, Ms. Doyle was an independent consultant to direct-to-consumer wellness businesses from 2014 to 2016. Ms. Doyle previously worked at Abbott Laboratories in various executive leadership roles from 2011 to 2014, including President of the Abbott Nutrition Product Division and, before that, Vice President and General Manager of Pediatric Nutrition. Prior to 2011, Ms. Doyle gained more than 20 years of experience at McKinsey & Company, Inc., including 10 years as Principal, working in the consumer packaged goods, consumer healthcare and retail sectors across Europe, Asia, Latin America and Africa. She currently serves as a director of AholdDelhaize, a global omnichannel grocery retailer, where she is the Chair of the Sustainability and Innovation Committee and serves on the Audit Committee. Previously, she served on the board of Bemis Company, Inc., a former publicly traded global packaging company, where she served on its Audit and Nomination and Governance Committees.
How old is Katherine Doyle?
Katherine Doyle is 51, she's been the Director of Perrigo plc since 2020. There are 24 older and 2 younger executives at Perrigo plc. The oldest executive at Perrigo Company plc is Rolf Classon, 75, who is the Independent Director.
What's Katherine Doyle's mailing address?
Katherine's mailing address filed with the SEC is C/O PERRIGO COMPANY PLC, 515 EASTERN AVENUE, ALLEGAN, MI, 49010.
Insiders trading at Perrigo plc
Over the last 11 years, insiders at Perrigo plc have traded over $21,020,805 worth of Perrigo plc stock and bought 592,512 units worth $38,708,035 . The most active insiders traders include Jeffrey C Smith, Gary M Cohen e Joseph C Papa. On average, Perrigo plc executives and independent directors trade stock every 11 days with the average trade being worth of $156,424. The most recent stock trade was executed by Ronald Craig Janish on 26 August 2024, trading 13,000 units of PRGO stock currently worth $382,200.
What does Perrigo plc do?
perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).
What does Perrigo plc's logo look like?
Complete history of Ms. Doyle stock trades at Abbott Laboratories e Perrigo plc
Perrigo plc executives and stock owners
Perrigo plc executives and other stock owners filed with the SEC include:
-
Murray Kessler,
President, Chief Executive Officer, Director -
Raymond Silcock,
Chief Financial Officer, Executive Vice President -
Murray S. Kessler,
CEO, Pres & Director -
Todd Kingma,
Executive Vice President, General Counsel, Company Secretary -
James Dillard,
Executive Vice President, Chief Scientific Officer -
Svend Andersen,
Executive Vice President, President - Consumer Healthcare International -
Sharon Kochan,
Executive Vice President, President - RX Pharmaceuticals -
Raymond P. Silcock,
CFO, Principal Accounting Officer & Exec. VP -
Svend Andersen,
Exec. VP & Pres of Consumer Healthcare International -
Richard S. Sorota,
Exec. VP & Pres of Consumer Self-Care Americas -
Todd W. Kingma,
Exec. VP, Gen. Counsel & Sec. -
James E. Dillard III,
Exec. VP & Pres of Consumer Self-Care Americas -
Rolf Classon,
Independent Director -
Donal O'Connor,
Independent Director -
Jeffrey Kindler,
Independent Director -
Theodore Samuels,
Independent Director -
Geoffrey Parker,
Independent Director -
Bradley Alford,
Independent Director -
Adriana Karaboutis,
Independent Director -
Erica Mann,
Independent Director -
Bradley Joseph,
Vice President Global Investor Relations -
Katherine Doyle,
Director -
Rich Sorota,
Executive Vice President and President - Consumer Self-Care Americas -
Grainne Quinn,
Executive Vice President, Chief Medical Officer -
Ronald Janish,
Executive Vice President - Global Operations and Supply Chain, Chief Transformation Officer -
Thomas Farrington,
Executive Vice President, Chief Information Officer -
Robert Willis,
Chief Human Resource Officer, Executive Vice President -
Kyle L. Hanson,
Exec. VP, Gen. Counsel & Corp. Sec. -
Alison Ives,
Exec. VP & Chief Scientific Officer -
Eduardo Guarita Bezerra,
Exec. VP & CFO -
Mary Reilly-Brest,
Director of Global Organizational and Human Resource Devel. -
Thomas M. Farrington,
Chief Information Officer & Exec. VP -
Shannon Hukill,
Sr. Director of Technical Operations -
Ronald C. Janish,
Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain -
Patrick Lockwood Taylor,
CEO -
Paul Weninger,
EVP, Quality Operations -
James R Michaud,
EVP, Chief HR Officer -
John T Hendrickson,
EVP Global Operations & Supply -
Gary M Cohen,
Director -
John Wesolowski,
EVP, President Rx -
Michael J Jandernoa,
Director -
Judy L Brown,
Executive VP & CFO -
Laurie Brlas,
Director -
Jeffrey C Smith,
Director -
Triona Schmelter,
EVP & President CSCA -
Uwe Roehrhoff,
CEO -
Ronald Winowiecki,
CFO -
David Ball,
EVP & CBDO -
Jacqualyn A Fouse,
Director -
Ellen Randi Hoffing,
Director -
Louis Yu,
Executive VP Global Quality -
Shlomo Yanai,
Director -
Marc Coucke,
Executive VP & GM -
Michael Robert Stewart,
Sr. VP Global Human Resources -
Joseph C Papa,
President and CEO -
Gary K Jr Kunkle,
Director -
Herman Jr Morris,
Director -
Ben Zion Zilberfarb,
Director -
Ran Gottfried,
Director -
Jatin Shah,
Sr VP & Chief Scientific Offic -
Scott F Jamison,
-
David T Gibbons,
Director -
Douglas Boothe,
EVP & GM Perrigo Pharma -
Jeffrey Needham,
EVP, President CHC Americas -
Orlando D Ashford,
Director -
Alison Ives,
EVP & Chief Scientific Officer -
Kyle Hanson,
EVP & General Counsel -
Eduardo Guarita Bezerra,
EVP & Chief Financial Officer -
Albert Manzone,
Director -
Julia M Brown,
Director